{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:43:22Z","timestamp":1790685802068,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shandong Province Medical Science and Technology Development Project","award":["2016WS0045"],"award-info":[{"award-number":["2016WS0045"]}]},{"name":"Shandong Province Key Research and Development Project","award":["2016GSF201021"],"award-info":[{"award-number":["2016GSF201021"]}]},{"name":"Shandong Province Higher Educational Science and Technology Project","award":["J16LL01"],"award-info":[{"award-number":["J16LL01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1442-6","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T02:40:26Z","timestamp":1520649626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of \u03b3-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation"],"prefix":"10.1186","volume":"16","author":[{"given":"Lei","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"1442_CR1","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.3390\/ijms19010179","volume":"19","author":"A Chiricozzi","year":"2018","unstructured":"Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 2018;19:E179.","journal-title":"Int J Mol Sci"},{"key":"1442_CR2","doi-asserted-by":"publisher","first-page":"E2684","DOI":"10.3390\/ijms18122684","volume":"18","author":"YR Woo","year":"2017","unstructured":"Woo YR, Cho DH, Park HJ. Molecular mechanisms and management of a cutaneous inflammatory disorder: psoriasis. Int J Mol Sci. 2017;18:E2684.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1442_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/exd.13467","volume":"27","author":"JG Krueger","year":"2018","unstructured":"Krueger JG, Brunner PM. Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities. Exp Dermatol. 2018;27(2):115\u201323.","journal-title":"Exp Dermatol."},{"key":"1442_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2040622317738910","volume":"9","author":"J Frieder","year":"2018","unstructured":"Frieder J, Kivelevitch D, Menter A. Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis. Ther Adv Chronic Dis. 2018;9:5\u201321.","journal-title":"Ther Adv Chronic Dis."},{"key":"1442_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445:866\u201373.","journal-title":"Nature"},{"key":"1442_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/1523-1747.ep12371679","volume":"101","author":"K Uyemura","year":"1993","unstructured":"Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by T-helper type 1 cell mediated response. J Invest Dermatol. 1993;101:349\u201356.","journal-title":"J Invest Dermatol."},{"key":"1442_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/cei.12086","volume":"173","author":"BJ Lewis","year":"2013","unstructured":"Lewis BJ, Rajpara S, Haggart AM, Wilson HM, Barker RN, Ormerod AD. Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions. Clin Exp Immunol. 2013;173:38\u201346.","journal-title":"Clin Exp Immunol"},{"key":"1442_CR8","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 2008;128:1207\u201311.","journal-title":"J Invest Dermatol."},{"key":"1442_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140:645\u201353.","journal-title":"J Allergy Clin Immunol."},{"key":"1442_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345\u201350.","journal-title":"Nat Immunol"},{"key":"1442_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821\u201352.","journal-title":"Annu Rev Immunol"},{"key":"1442_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1203475415584503","volume":"19","author":"C Fotiadou","year":"2015","unstructured":"Fotiadou C, Lazaridou E, Sotiriou E, et al. IL-17A, IL-22, and IL-23 as markers of psoriasis activity: a cross-sectional, hospital-based study. J Cutan Med Surg. 2015;19:555\u201360.","journal-title":"J Cutan Med Surg."},{"key":"1442_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","volume":"7","author":"CW Lynde","year":"2014","unstructured":"Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S. Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol. 2014;7:141\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"1442_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/CE.S33940","volume":"9","author":"S Coimbra","year":"2014","unstructured":"Coimbra S, Figueiredo A, Santos-Silva A. Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis. Core Evid. 2014;9:89\u201397.","journal-title":"Core Evid."},{"key":"1442_CR15","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1365-2133.2010.09992.x","volume":"163","author":"S Coimbra","year":"2010","unstructured":"Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumor necrosis factor-\u03b1 levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol. 2010;163:1282\u201390.","journal-title":"Br J Dermatol"},{"key":"1442_CR16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1242\/jcs.127308","volume":"126","author":"K Hori","year":"2013","unstructured":"Hori K, Sen A, Artavanis-Tsakonas S. Notch signaling at a glance. J Cell Sci. 2013;126:2135\u201340.","journal-title":"J Cell Sci"},{"key":"1442_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri3445","volume":"13","author":"F Radtke","year":"2013","unstructured":"Radtke F, MacDonald HR, Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol. 2013;13:427\u201337.","journal-title":"Nat Rev Immunol"},{"key":"1442_CR18","first-page":"115","volume":"360","author":"F Auderset","year":"2012","unstructured":"Auderset F, Coutaz M, Tacchini F. The role of Notch in the differentiation of CD4+ T helper cells. Curr Top Microbiol Immunol. 2012;360:115\u201334.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1442_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.it.2015.10.007","volume":"36","author":"D Amsen","year":"2015","unstructured":"Amsen D, Helbig C, Backer RA. Notch in T cell differentiation: all things considered. Trends Immunol. 2015;36:802\u201314.","journal-title":"Trends Immunol"},{"key":"1442_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4049\/jimmunol.1003658","volume":"187","author":"S Keerthivasan","year":"2011","unstructured":"Keerthivasan S, Suleiman R, Lawlor R, et al. Notch signaling regulates mouse and human Th17 differentiation. J Immunol. 2011;187:692\u2013701.","journal-title":"J Immunol."},{"key":"1442_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.anndiagpath.2011.09.005","volume":"16","author":"AG Abdou","year":"2012","unstructured":"Abdou AG, Maraee AH, Sharaf A, Elnaidany NF. Up-regulation of Notch-1 in psoriasis: an immunohistochemical study. Ann Diagn Pathol. 2012;16:177\u201384.","journal-title":"Ann Diagn Pathol."},{"key":"1442_CR22","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Fits van der","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol. 2009;182:5836\u201345.","journal-title":"J Immunol."},{"key":"1442_CR23","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","volume":"180","author":"AS Haider","year":"2008","unstructured":"Haider AS, Lowes MA, Su\u00e1rez-Fari\u00f1as M, et al. Identification of cellular pathways of \u201ctype 1,\u201d Th17 T cells, and TNF- and inducible nitric oxide synthase- producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol. 2008;180:1913\u201320.","journal-title":"J Immunol."},{"key":"1442_CR24","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1084\/jem.20071094","volume":"204","author":"LC Zaba","year":"2007","unstructured":"Zaba LC, Cardinale I, Gilleaudeau P, et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med. 2007;204:3183\u201394.","journal-title":"J Exp Med"},{"key":"1442_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","volume":"68","author":"J Kim","year":"2017","unstructured":"Kim J, Krueger JG. Highly effective new treatments for psoriasis target the IL-23\/Type 17 T cell autoimmune axis. Annu Rev Med. 2017;68:255\u201369.","journal-title":"Annu Rev Med"},{"key":"1442_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2174\/1574888X113089990054","volume":"8","author":"H Nagase","year":"2013","unstructured":"Nagase H, Nakayama K. \u03b3-Secretase-regulated signaling typified by Notch signaling in the immune system. Curr Stem Cell Res Ther. 2013;8:341\u201356.","journal-title":"Curr Stem Cell Res Ther"},{"key":"1442_CR27","doi-asserted-by":"publisher","first-page":"62799","DOI":"10.18632\/oncotarget.11715","volume":"7","author":"C Dorneburg","year":"2016","unstructured":"Dorneburg C, Goss AV, Fischer M, et al. \u03b3-secretase\u00a0inhibitor\u00a0i\u00a0inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets. Oncotarget. 2016;7:62799\u2013813.","journal-title":"Oncotarget."},{"key":"1442_CR28","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1074\/jbc.M513012200","volume":"281","author":"Y Morohashi","year":"2006","unstructured":"Morohashi Y, Kan T, Tominari Y, et al. C-terminal\u00a0fragment\u00a0of\u00a0presenilin\u00a0is the\u00a0molecular\u00a0target\u00a0of a\u00a0dipeptidic\u00a0gamma-secretase-specific inhibitor\u00a0DAPT (N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine\u00a0t-butyl\u00a0ester). J Biol Chem. 2006;281:14670\u20136.","journal-title":"J Biol Chem"},{"key":"1442_CR29","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.4049\/jimmunol.0804322","volume":"182","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol. 2009;182:7381\u20138.","journal-title":"J Immunol."},{"key":"1442_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00403-015-1594-7","volume":"307","author":"E Skarmoutsou","year":"2015","unstructured":"Skarmoutsou E, Trovato C, Granata M. Biological therapy induces expression changes in Notch pathway in psoriasis. Arch Dermatol Res. 2015;307:863\u201373.","journal-title":"Arch Dermatol Res"},{"key":"1442_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","volume":"33","author":"J Kim","year":"2015","unstructured":"Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin. 2015;33:13\u201323.","journal-title":"Dermatol Clin"},{"key":"1442_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"1442_CR33","doi-asserted-by":"publisher","first-page":"e14108","DOI":"10.1371\/journal.pone.0014108","volume":"5","author":"PC Res","year":"2010","unstructured":"Res PC, Piskin G, de Boer OJ, et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE. 2010;5:e14108.","journal-title":"PLoS ONE"},{"key":"1442_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","volume":"35","author":"Y Cai","year":"2011","unstructured":"Cai Y, Shen X, Ding C, et al. Pivotal\u00a0role\u00a0of\u00a0dermal IL-17-producing \u03b3\u03b4T cells in skin inflammation. Immunity. 2011;35:596\u2013610.","journal-title":"Immunity"},{"key":"1442_CR35","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1172\/JCI61862","volume":"122","author":"S Pantelyushin","year":"2012","unstructured":"Pantelyushin S, Haak S, Ingold B, et al. Ror\u03b3t+ innate\u00a0lymphocytes\u00a0and \u03b3\u03b4T\u00a0cells\u00a0initiate\u00a0psoriasiform\u00a0plaque formation\u00a0in\u00a0mice. J Clin Invest. 2012;122:2252\u20136.","journal-title":"J Clin Invest."},{"key":"1442_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1182\/blood-2011-02-334995","volume":"118","author":"K Shibata","year":"2011","unstructured":"Shibata K, Yamada H, Sato T, et al. Notch-Hes1 pathway is required for the development of IL-17-producing \u03b3\u03b4 T cells. Blood. 2011;118:586\u201393.","journal-title":"Blood"},{"key":"1442_CR37","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","volume":"140","author":"M Gilliet","year":"2004","unstructured":"Gilliet M, Conrad C, Geiges M, et al. Psoriasis triggered by Toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 2004;140:1490\u20135.","journal-title":"Arch Dermatol"},{"key":"1442_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","volume":"45","author":"JK Wu","year":"2004","unstructured":"Wu JK, Siller G, Strutton G. Psoriasis\u00a0induced\u00a0by\u00a0topical\u00a0imiquimod. Australas J Dermatol. 2004;45:47\u201350.","journal-title":"Australas J Dermatol"},{"key":"1442_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2230.2005.01938.x","volume":"31","author":"N Rajan","year":"2016","unstructured":"Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermal. 2016;31:140\u20131.","journal-title":"Clin Exp Dermal."},{"key":"1442_CR40","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/j.1365-4632.2006.02980.x","volume":"45","author":"PA Fanti","year":"2006","unstructured":"Fanti PA, Dika E, Vaccari S, Miscial C, Varotti C. Generalized\u00a0psoriasis induced by\u00a0topical\u00a0treatment\u00a0of\u00a0actinic\u00a0keratosis\u00a0with\u00a0imiquimod. Int J Dermatol. 2006;45:1464\u20135.","journal-title":"Int J Dermatol"},{"key":"1442_CR41","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.4049\/jimmunol.173.5.3051","volume":"173","author":"F Palamara","year":"2004","unstructured":"Palamara F, Meindl S, Holcmann M, L\u00fchrs P, Stingl G, Sibilia M. Identification\u00a0and\u00a0characterization\u00a0of\u00a0pDC-like\u00a0cells\u00a0in\u00a0normal\u00a0mouse\u00a0skin\u00a0and melanomas treated with imiquimod. J Immunol. 2004;173:3051\u201361.","journal-title":"J Immunol."},{"key":"1442_CR42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.coi.2006.09.014","volume":"18","author":"V Pascual","year":"2006","unstructured":"Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol. 2006;18:676\u201382.","journal-title":"Curr Opin Immunol"},{"key":"1442_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nm1590","volume":"13","author":"R Baccala","year":"2007","unstructured":"Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med. 2007;13:543\u201351.","journal-title":"Nat Med"},{"key":"1442_CR44","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.38298","volume":"66","author":"M Yokogawa","year":"2014","unstructured":"Yokogawa M, Takaishi M, Nakajima K, et al. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic lupus erythematosus. Arthritis Rheumatol. 2014;66:694\u2013706.","journal-title":"Arthritis Rheumatol."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1442-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1442-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1442-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T00:07:15Z","timestamp":1552176435000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1442-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1442-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,10]]},"assertion":[{"value":"15 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"59"}}